Advances in the role of growth differentiation factor 11 in cardiovascular diseases

doi:10.3969/j.issn.1674-8115.2021.06.023

Abstract

Abstract:

Growth differentiation factor 11 (GDF11) is an important member of transforming growth factor-β (TGF-β) superfamily. As a secreted protein widely distributed in human body, it is associated with many physiological activities, including early embryonic and bone development, neural regulation, and maturation of tissues and organs such as retina and kidney. Recent studies have shown that GDF11 is closely related to aging and cardiovascular diseases, but its specific effects and mechanism are controversial. Some studies have drawn the conclusions that increased levels of GDF11 can reduce myocardial hypertrophy, alleviate inflammatory damage and protect the function of vascular endothelial cells. Meanwhile, some studies have reached the opposite conclusions. So the issue that whether GDF11 has a protective effect on cardiovascular diseases remains uncertain. This article reviews the research progress and essential divergence of GDF11 in the field of cardiovascular diseases, in order to provide reference for future investigation.

Key words: growth differentiation factor 11, cardiovascular diseases, cardiac hypertrophy, aging

CLC Number:

R541

Ming-qi CAI, Yan CHEN, Kai-bin LIN, Dong HUANG. Advances in the role of growth differentiation factor 11 in cardiovascular diseases[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 834-838.

TrendMD

References 42

1	Roth GA, Johnson C, Abajobir A, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015[J]. J Am Coll Cardiol, 2017, 70(1): 1-25.
2	Nakashima M, Toyono T, Akamine A, et al. Expression of growth/differentiation factor 11, a new member of the BMP/TGFβ superfamily during mouse embryogenesis[J]. Mech Dev, 1999, 80(2): 185-189.
3	Oxburgh L. TGF superfamily signals are required for morphogenesis of the kidney mesenchyme progenitor population[J]. Development, 2004, 131(18): 4593-4605.
4	Dichmann DS, Yassin H, Serup P. Analysis of pancreatic endocrine development in GDF11-deficient mice[J]. Dev Dyn, 2006, 235(11): 3016-3025.
5	Gokoffski KK, Wu HH, Beites CL, et al. Activin and GDF11 collaborate in feedback control of neuroepithelial stem cell proliferation and fate[J]. Dev Camb Engl, 2011, 138(19): 4131-4142.
6	Li Z, Zeng F, Mitchell AD, et al. Transgenic overexpression of bone morphogenetic protein 11 propeptide in skeleton enhances bone formation[J]. Biochem Biophys Res Commun, 2011, 416(3): 289-292.
7	Loffredo FS, Steinhauser ML, Jay SM, et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy[J]. Cell, 2013, 153(4): 828-839.
8	Zhang YH, Wei Y, Liu D, et al. Role of growth differentiation factor 11 in development, physiology and disease[J]. Oncotarget, 2017, 8(46): 81604-81616.
9	Egerman MA, Glass DJ. The role of GDF11 in aging and skeletal muscle, cardiac and bone homeostasis[J]. Crit Rev Biochem Mol Biol, 2019, 54(2): 174-183.
10	Kondás K, Szláma G, Trexler M, et al. Both WFIKKN₁ and WFIKKN₂ have high affinity for growth and differentiation factors 8 and 11[J]. J Biol Chem, 2008, 283(35): 23677-23684.
11	Jamaiyar A, Wan W, Janota DM, et al. The versatility and paradox of GDF 11[J]. Pharmacol Ther, 2017, 175: 28-34.
12	Roh JD, Hobson R, Chaudhari V, et al. Activin type II receptor signaling in cardiac aging and heart failure[J]. Sci Transl Med, 2019, 11(482): eaau8680.
13	Su HH, Liao JM, Wang YH, et al. Exogenous GDF11 attenuates non-canonical TGF-β signaling to protect the heart from acute myocardial ischemia-reperfusion injury[J]. Basic Res Cardiol, 2019, 114(3): 20.
14	Zhang YH, Cheng F, Du XT, et al. GDF11/BMP11 activates both smad1/5/8 and smad2/3 signals but shows no significant effect on proliferation and migration of human umbilical vein endothelial cells[J]. Oncotarget, 2016, 7(11): 12063-12074.
15	Euler-Taimor G, Heger J. The complex pattern of SMAD signaling in the cardiovascular system[J]. Cardiovasc Res, 2006, 69(1): 15-25.
16	Khalil H, Kanisicak O, Prasad V, et al. Fibroblast-specific TGF-β-Smad2/3 signaling underlies cardiac fibrosis[J]. J Clin Investig, 2017, 127(10): 3770-3783.
17	Hanna A, Frangogiannis NG. The role of the TGF-β superfamily in myocardial infarction[J]. Front Cardiovasc Med, 2019, 6: 140.
18	Walker RG, Czepnik M, Goebel EJ, et al. Structural basis for potency differences between GDF₈ and GDF₁₁[J]. BMC Biol, 2017, 15(1): 1-22.
19	Tarver T. Heart disease and stroke statistics–2014 update: a report from the American heart association[J]. J Consumer Heal Internet, 2014, 18(2): 209.
20	Egerman MA, Cadena SM, Gilbert JA, et al. GDF11 increases with age and inhibits skeletal muscle regeneration[J]. Cell Metab, 2015, 22(1): 164-174.
21	Poggioli T, Vujic A, Yang P, et al. Circulating growth differentiation factor 11/8 levels decline with age[J]. Circ Res, 2016, 118(1): 29-37.
22	Schafer MJ, Atkinson EJ, Vanderboom PM, et al. Quantification of GDF11 and myostatin in human aging and cardiovascular disease[J]. Cell Metab, 2016, 23(6): 1207-1215.
23	Olson KA, Beatty AL, Heidecker B, et al. Association of growth differentiation factor 11/8, putative anti-ageing factor, with cardiovascular outcomes and overall mortality in humans: analysis of the Heart and Soul and HUNT3 cohorts[J]. Eur Heart J, 2015, 36(48): 3426-3434.
24	Zhou Y, Ni SS, Song LL, et al. Late-onset administration of GDF11 extends life span and delays development of age-related markers in the annual fish Nothobranchius guentheri[J]. Biogerontology, 2019, 20(2): 225-239.
25	Sinha M, Jang YC, Oh J, et al. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle[J]. Science, 2014, 344(6184): 649-652.
26	Ozek C, Krolewski RC, Buchanan SM, et al. Growth differentiation factor 11 treatment leads to neuronal and vascular improvements in the hippocampus of aged mice[J]. Sci Rep, 2018, 8(1): 17293.
27	Li H, Li YX, Xiang LW, et al. GDF11 attenuates development of type 2 diabetes via improvement of islet β-cell function and survival[J]. Diabetes, 2017, 66(7): 1914-1927.
28	Aurigemma GP. Diastolic heart failure: a common and lethal condition by any name[J]. N Engl J Med, 2006, 355(3): 308-310.
29	Smith SC, Zhang XX, Zhang XY, et al. GDF11 does not rescue aging-related pathological hypertrophy[J]. Circ Res, 2015, 117(11): 926-932.
30	Zimmers TA, Jiang YL, Wang MJ, et al. Erratum to: exogenous GDF11 induces cardiac and skeletal muscle dysfunction and wasting[J]. Basic Res Cardiol, 2017, 112(5): 53.
31	Harper SC, Johnson J, Borghetti G, et al. GDF11 decreases pressure overload-induced hypertrophy, but can cause severe cachexia and premature death[J]. Circ Res, 2018, 123(11): 1220-1231.
32	Zhang CJ, Wang Y, Ge ZR, et al. GDF11 attenuated ANG II-induced hypertrophic cardiomyopathy and expression of ANP, BNP and β-MHC through down- regulating CCL11 in mice[J]. Curr Mol Med, 2018, 18(10): 661-671.
33	Duran J, Troncoso M, Lagos D, et al. GDF11 modulates Ca²⁺-dependent Smad2/3 signaling to prevent cardiomyocyte hypertrophy[J]. Int J Mol Sci, 2018, 19(5): 1508.
34	Garrido-Moreno V, Díaz-Vegas A, López-Crisosto C, et al. GDF-11 prevents cardiomyocyte hypertrophy by maintaining the sarcoplasmic reticulum-mitochondria communication[J]. Pharmacol Res, 2019, 146: 104273.
35	Garbern J, Kristl AC, Bassaneze V, et al. Analysis of Cre-mediated genetic deletion of Gdf11 in cardiomyocytes of young mice[J]. Am J Physiol Heart Circ Physiol, 2019, 317(1): H201-H212.
36	Mei W, Xiang GD, Li YX, et al. GDF11 protects against endothelial injury and reduces atherosclerotic lesion formation in apolipoprotein E-null mice[J]. Mol Ther, 2016, 24(11): 1926-1938.
37	Zhao L, Zhang SH, Cui J, et al. TERT assists GDF11 to rejuvenate senescent VEGFR2⁺/CD133⁺ cells in elderly patients with myocardial infarction[J]. Lab Investig J Tech Methods Pathol, 2019, 99(11): 1661-1688.
38	Du GQ, Shao ZB, Wu J, et al. Targeted myocardial delivery of GDF11 gene rejuvenates the aged mouse heart and enhances myocardial regeneration after ischemia-reperfusion injury[J]. Basic Res Cardiol, 2016, 112(1): 1-14.
39	Zhou B, Yu YL, Qiu Z, et al. GDF11 ameliorated myocardial ischemia reperfusion injury by antioxidant stress and up-regulating autophagy in STZ-induced type 1 diabetic rats[J]. Acta Cir Bras, 2019, 34(11). DOI:10.1590/s0102-865020190110000006.
40	Zhang XJ, Tan H, Shi ZF, et al. Growth differentiation factor 11 is involved in isoproterenol-induced heart failure[J]. Mol Med Rep, 2019, 19(5): 4109-4118.
41	Rochette L, Malka G. Neuroprotective potential of GDF11: myth or reality?[J]. Int J Mol Sci, 2019, 20(14): 3563.
42	Simoni-Nieves A, Gerardo-Ramírez M, Pedraza-Vázquez G, et al. GDF11 implications in cancer biology and metabolism. facts and controversies[J]. Front Oncol, 2019, 9: 1039.

[1]	Jiang-lei MA, Xiao-yao LI, Shi-fu ZHAO, De-jun YANG. Advances in diagnostic methods of clinical staging for gastric cancer [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 821-825.
[2]	Hua-jie DAI, Li-ping XUAN, Jia-li XIANG, Hong LIN, Zhi-yun ZHAO, Tian-ge WANG, Mian LI, Yu XU, Jie-li LU, Wei-qing WANG, Yu-fang BI, Min XU. Correlation between healthy vascular aging and prevalent cardiovascular disease risk in middle-aged and elderly people in the community of Shanghai [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(2): 223-227.
[3]	Lin-xiu-mei GUO, Yi-xin ZHANG. Application of skin autofluorescence detection technique to diagnosis of diseases [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(2): 251-256.
[4]	Xiao-min LI, Yang QU, Shao-ting ZHANG, Liang ZHAO, Chang LIU, Shuai-ning XIE, Ke-rong DAI, Song-tao AI. Overview of the application of artificial intelligence to radiology of the musculoskeletal system [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(2): 262-266.
[5]	Xiu-ying LIU, Rui-fang LAN. Correlation between quantitative electroencephalogram features and CT perfusion imaging parameters in acute ischemic stroke [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(1): 62-65.
[6]	CHEN Mo, CHEN Jun, CHEN Shi-yi. Advances in second near-infrared fluorescent nanoprobes-based in vivo imaging for biomedical applications [J]. , 2020, 40(4): 530-.
[7]	YANG Tao, CHEN Jun, FANG Yi-ru. Advances in magnetic resonance imaging study of bipolar Ⅰdisorder [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(12): 1660-1664.
[8]	YUE Xiu-hui, KONG Wei-dan, REN Ji-liang, YUAN Ying#, TAO Xiao-feng#. Value of 3.0-T MR diffusion-weighted imaging combined with dynamic contrast-enhanced imaging in differentiating benign and malignant thyroid nodules [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(10): 1393-1397.
[9]	LI Xiao-min1, QU Yang1, WU Wen2, ZHAO Liang3, ZHANG Shao-ting3, HAO Yong-qiang2, DAI Ke-rong2, AI Song-tao1. Preliminary application of MR imaging-pathology co-localization by 3D printing box in pelvic tumor assessment [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(10): 1408-1413.
[10]	WANG Tao, ZHANG Chen-cheng, LI Dian-you, SUN Bo-min, FU Meng. Imaging law of postoperative electrode locations in deep brain stimulation for Parkinsons disease [J]. , 2020, 40(1): 64-.
[11]	HAN Rui-jun, DU Jing, CHEN Cui, ZHU Cai-xia, LI Feng-hua, WANG Jia-dong. Diagnostic efficiency of ultrasound TI-RADS combined with three-dimensional shear wave elastography in thyroid microcarcinoma [J]. , 2020, 40(1): 76-.
[12]	LUAN Wei, ZHU Zhu, ZHU Dong-ping, GE Wen-jing, ZHU Qun-mei, JIANG Yan-qing, LI Jin, JIANG An-li. Relationship of health promotion lifestyle with social support and self-efficacy of the elderly in urban-rural communities [J]. , 2020, 40(1): 107-.
[13]	ZHU Lin, LIU Jun. Progress in biomarkers of multiple system atrophy [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(09): 1302-1307.
[14]	JI Ying-ying, XUE Bin, HUANG Yue, ZHANG Jian-wei. Efficacy and safety of oral midazolam in combination with intranasal dexmedetomidine for paediatric magnetic resonance imaging sedation [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(08): 1098-1102.
[15]	XIA Zhi-peng1, YUAN Ying2, YANG Xi2, GU Hao2, LIN Xiao-xi 2#, TAO Xiao-feng1#. Value of dynamic contrast-enhanced MRI in selecting sclerosants for endovascular sclerosis of venous malformation [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(07): 873-880.